UMH Properties: the 2026 and 2027 refinancing test

The main article on UMH Properties already established the Q1 operating read: occupancy improved, NOI moved higher, but Normalized FFO per share stayed at $0.23. This continuation isolates the constraint that can decide whether that operating improvement reaches common shareholders: the funding window in late 2026 and early 2027.

This is not an immediate cash crisis. At March 31, 2026, the company had $37.4 million of cash, $26.4 million of marketable securities, $260 million available under its unsecured credit facility, and additional lines for inventory, home sales financing and rental homes. But that is only half the picture. The unsecured facility itself matures on November 7, 2026, the $102.7 million Series A bonds mature on February 28, 2027, and coverage ratios weakened just as management is asking investors to view higher interest cost as the temporary price of assets that have not yet fully started earning.

The financing test is not survival. It is price. If the banks renew the facility on reasonable terms and the company shows a clear source for the Series A maturity, the market can read 2026 as a financing bridge year. If renewal comes with a higher cost, tighter terms, or heavy use of common or preferred ATM capacity, rising NOI can still remain too far away from the common share.

Liquidity is available, but the renewal window already matters

The unsecured credit facility is the most important item that does not show up in a standard debt maturity schedule. There was no balance outstanding at quarter end, so it does not inflate reported debt. Yet it gives the company access to $260 million, with potential total availability of up to $500 million through an accordion feature. It is a flexibility tool, not just a line item.

The problem is timing. The facility is syndicated with BMO Capital Markets, JPMorgan Chase Bank and Wells Fargo, and bears interest based on the company’s overall leverage ratio: SOFR plus 1.5% to 2.20%, or BMO prime plus 0.50% to 1.20%. It matures on November 7, 2026, and the company is already in discussions with the banks to renew it. No balance outstanding at quarter end is good for the balance sheet snapshot, but it does not remove dependence on the renewal itself.

The table separates debt already drawn from access to financing. The maturity schedule shows existing debt. The unsecured facility shows the ability to replace, roll or add financing. If renewed on good terms, it reduces the risk around 2027. If renewed at a higher cost, it can turn the Series A maturity from a single repayment event into a broader capital-structure test.

The maturity schedule is not heavy, but it is badly timed

The company’s reported debt maturity schedule does not show a classic wall. Out of $771.2 million of debt before issuance costs, $43.2 million matures in 2026 and $139.4 million matures in 2027. Together, that is 23.7% of debt before issuance costs. The amount looks manageable relative to the asset base and available liquidity, but it lands before the operating improvement has fully proven that it can absorb interest cost and the preferred dividend layer.

Series A is not the company’s only large debt item, but it is the nearest one that changes the conversation. Series B of $80.2 million sits in 2030, and the large mortgage tail comes later. That is why the window from 2026 to early 2027 should be assessed not only by the amount due, but by the company’s ability to preserve access to credit before interest cost and dilution rewrite the economics per share.

The Series A structure also matters. It is an unsecured obligation, denominated in Israeli shekels, with principal and interest linked to the U.S. dollar. The coupon is 4.72%. The rate can increase after a downgrade of two or more notches or a covenant breach, up to an aggregate increase of 1.25% per year. At March 31, 2026, the company was in compliance with the covenants, but the filing does not provide detailed numerical headroom. That means there is no basis for saying the covenants are close to breach. There is a basis for saying that any additional deterioration in coverage will be read through the credit facility renewal and the Series A maturity.

Coverage weakened before the refinancing was done

The company is not entering this window with weak operations. Adjusted EBITDA excluding non-recurring other expense rose to $32.8 million in Q1, from $29.4 million a year earlier. The problem is that financing costs moved faster. Interest expense rose to $9.1 million from $5.9 million, and total fixed charges, including capitalized interest and preferred dividends, rose to $15.7 million from $12.4 million.

That is how the ratio drift appears. Interest coverage fell to 3.1x from 4.1x a year earlier, and fixed-charge coverage fell to 2.1x from 2.4x. Net debt to Adjusted EBITDA rose to 5.5x from 4.9x, and the ratio including preferred stock remained much higher: 8.0x versus 7.6x a year earlier.

This is not just an accounting issue. Management itself says earnings were affected by substantially higher interest expense, partly because of refinancing activity and the new bond issuance, and because interest on completed lots and added rental units is expensed at completion. In other words, the investment is already showing up in financing cost, while the full income is expected only once the homes and sites begin earning. That is why the next few quarters matter: if NOI and occupancy rise fast enough, coverage can stabilize. If not, financing cost will continue to arrive before the income.

Preferred stock makes the debt test broader

Series D preferred stock is not debt, but it sits above the common share in the cash waterfall. At March 31, 2026, the preferred layer was $324.6 million, and the quarterly preferred dividend was $5.2 million. When added to net debt, the ratio to total market capitalization rises to 45.3%, compared with 31.2% for net debt alone.

That gap matters. A company can refinance debt, keep NOI growing, and still leave common shareholders with flat FFO per share. That is exactly what happened in Q1: Normalized FFO rose to $19.4 million from $18.8 million, but Normalized FFO per share stayed at $0.23. The common share sees improvement only after interest, preferred dividends and share count.

The ATM capacity shows the same dilemma. In Q1, the company did not sell common shares under its ATM program, and $44.6 million remained eligible for sale. It did sell 66,000 preferred shares at a weighted average price of $22.51, generating $1.5 million of net proceeds, with $97.5 million of preferred stock still eligible for sale. These are flexibility sources, but they are not free. Meaningful use can solve liquidity while leaving the common-share return question open.

The all-in cash picture explains why market access still matters

The cash framing matters here. All-in cash flexibility means cash left after the period’s actual uses: investment and development spending, dividends, debt repayment, financing costs, and the equity sources the company used. This is not normalized cash generation before growth CAPEX, so it is the more relevant frame for a refinancing analysis.

In Q1, operating cash flow was $20.8 million. Against that, the company used $33.2 million for investing activities, mainly $24.4 million for investment property and equipment and $9.5 million for land development costs. Financing cash outflows included $18.1 million of common dividends net of dividend reinvestment, $5.2 million of preferred dividends, and $2.3 million of mortgage and loan principal payments. Offsetting sources were roughly $3.0 million from preferred issuance, the DRIP net of reinvested dividends, option exercises and net short-term borrowings.

The result was a $35.0 million decrease in cash, restricted cash and cash equivalents. That is not a warning signal by itself, because a growing real estate company normally invests before assets stabilize. But it explains why the facility renewal matters more than the quarter-end balance. As long as the company is investing, paying dividends and pursuing growth, it needs banks and capital markets to stay available. In a quarter with no common ATM sales and no draw on the unsecured facility, liquidity looks cleaner. In a year with a facility renewal and the Series A maturity approaching, the question is how long that can remain true.

2026 is becoming a financing bridge year

Management narrowed 2026 Normalized FFO guidance to $0.98 to $1.04 per share, compared with a previous range of $0.97 to $1.05. The midpoint remains around $1.01. After a Q1 result of $0.23, the next three quarters need to produce $0.75 to $0.81 in total, or about $0.25 to $0.27 per share each quarter, to meet the annual range.

That is achievable only if management’s explanation plays out: a harsh winter that weighed on home sales and community expenses, stronger spring and summer seasonality, additional occupancy, NOI and sales growth, and recent investments becoming income-producing. The link to financing is direct. Strong Q2 and Q3 results would make it easier for banks and bondholders to read late 2026 as a normal renewal window. Another quarter of rising NOI with flat FFO per share would strengthen the concern that interest, preferred dividends and share count are still absorbing the asset-level progress.

The milestones are clear. First, the unsecured facility needs to be renewed before November 2026 without reducing operating flexibility. Second, the company needs a clear source for Series A before February 2027, not a last-minute dependence on the Israeli debt market. Third, coverage ratios need to stop weakening. Fourth, the all-in cash picture needs to become less dependent on securities sales, ATM capacity or new credit draws.

The refinancing test is really a per-share translation test

UMH Properties continues to improve at the asset level, but the 2026 and 2027 financing window will decide how much of that improvement remains for common shareholders. The company enters the window with liquidity, unencumbered assets and access to credit facilities. It does not enter it with improving coverage.

The current conclusion is straightforward: the credit facility renewal and Series A maturity are manageable financing events, but they are no longer technical. They will decide whether 2026 looks like a bridge year in which capital cost temporarily moved ahead of income, or a year in which asset-level growth keeps getting stuck in the financing layers.

The counter-thesis is credible. If the banks renew the facility, spring and summer lift FFO per share, and Series A is refinanced without aggressive dilution or meaningful new collateral pressure, the market can treat this debate as temporary financing noise around a REIT with good assets. Until then, the company should be read through three numbers: the price of the credit facility renewal, the source of the Series A repayment, and fixed-charge coverage.